Subscribe
ugisrigba
Ugis Rigba / Shutterstock.com
18 June 2020Big PharmaRory O'Neill

EC backs voluntary COVID-19 vaccine licensing

The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
EU concludes COVID-19 vaccine talks with Pfizer
10 September 2020   The European Commission has concluded exploratory talks with Pfizer and BioNTech to potentially supply 300 million doses of their investigational vaccine against COVID-19.
Big Pharma
CPI receives £5m from UK govt for 'vaccine library'
4 March 2021   UK innovation hub CPI has received a further £5 million investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19.
Big Pharma
Ghana in licensing talks to manufacture AstraZeneca vaccine
27 April 2021   Ghana’s pharmaceutical industry has asked AstraZeneca about acquiring rights to produce its COVID vaccine locally, buoying the country’s inoculation efforts.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
EU concludes COVID-19 vaccine talks with Pfizer
10 September 2020   The European Commission has concluded exploratory talks with Pfizer and BioNTech to potentially supply 300 million doses of their investigational vaccine against COVID-19.
Big Pharma
CPI receives £5m from UK govt for 'vaccine library'
4 March 2021   UK innovation hub CPI has received a further £5 million investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19.
Big Pharma
Ghana in licensing talks to manufacture AstraZeneca vaccine
27 April 2021   Ghana’s pharmaceutical industry has asked AstraZeneca about acquiring rights to produce its COVID vaccine locally, buoying the country’s inoculation efforts.

More on this story

Big Pharma
EU concludes COVID-19 vaccine talks with Pfizer
10 September 2020   The European Commission has concluded exploratory talks with Pfizer and BioNTech to potentially supply 300 million doses of their investigational vaccine against COVID-19.
Big Pharma
CPI receives £5m from UK govt for 'vaccine library'
4 March 2021   UK innovation hub CPI has received a further £5 million investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19.
Big Pharma
Ghana in licensing talks to manufacture AstraZeneca vaccine
27 April 2021   Ghana’s pharmaceutical industry has asked AstraZeneca about acquiring rights to produce its COVID vaccine locally, buoying the country’s inoculation efforts.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility